CollPlant Biotechnologies (CLGN) Non-Current Assets (2017 - 2026)

CollPlant Biotechnologies has reported Non-Current Assets for 10 years, with the latest figure at $3.6 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 99.93% year-over-year to $3.6 million; the trailing twelve-month figure through Mar 2026 stood at $3.6 million (down 99.93% YoY), and the FY2025 full-year result was $4.0 million, down 99.93% from the prior year.
• Non-Current Assets for Q1 2026 stood at $3.6 million, down from $4.0 million in the prior quarter.
• The five-year high for Non-Current Assets was $6.4 billion in Q3 2023, with the low at $3.6 million in Q1 2026.
• Historically, Non-Current Assets has averaged $2.2 billion across 5 years, with a median of $6.5 million in 2023.
• Annual changes were most pronounced in 2023 — Non-Current Assets soared 104083.07% — and 2026, when it tumbled 99.93%.
• CollPlant Biotechnologies' Non-Current Assets stood at $6.1 billion in 2022, then slumped by 99.9% to $6.1 million in 2023, then surged by 90496.33% to $5.5 billion in 2024, then slumped by 99.93% to $4.0 million in 2025, then declined by 9.76% to $3.6 million in 2026.
• The last three Non-Current Assets figures came in at $3.6 million (Q1 2026), $4.0 million (Q4 2025), and $4.8 million (Q2 2025), per Business Quant data.